Advanced Oncotherapy PLC
LSE:AVO

Watchlist Manager
Advanced Oncotherapy PLC Logo
Advanced Oncotherapy PLC
LSE:AVO
Watchlist
Price: 1.925 GBX Market Closed
Market Cap: £9.1m

Advanced Oncotherapy PLC
Investor Relations

Advanced Oncotherapy Plc engages in the development of proton therapy systems. The firm is focused on developing and supplying technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to the patient's healthy tissues. The linear design of LIGHT allows for an active longitudinal modulation along the proton beam axis, and the variation of the proton beam by electronic means during cancer treatment. The feature of LIGHT offers hospitals and treatment centers the flexibility to customize cancer treatment plans based on a range of energies. This could provide an alternative to passive modulation, that degrades the beam along its path, causing it to lose integrity. In addition, a dynamic transversal modulation allows a precise three dimensional (3D) treatment of the tumors via the spot scanning technique.

Show more
Loading
AVO
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Michael Jeffrey Sinclair
Exec. Chairman
No Bio Available
Mr. Nicolas Serandour
CEO & Exec. Director
No Bio Available
Prof. Stephen Myers OBE
Exec. Director
No Bio Available
Mr. Ed Lee
COO & Pres of Europe
No Bio Available
Mr. Graham Pughe
Sr. Vice-Pres of Accounting
No Bio Available
Ms. Berengere Pons-Chabord
Sr. Vice-Pres of Corp. Fin.
No Bio Available
Dr. Manuel Gallas
Director of Technical & Engineering
No Bio Available
Mr. David Navas
VP of Investor and PR
No Bio Available
Ms. Bridget Biggar
Director of HR
No Bio Available
Ms. Donatella Ungaro
Managing Director of ADAM
No Bio Available

Contacts

Address
London
Third Fl, 4 Tenterden Street
Contacts
+442036178728.0
www.avoplc.com